These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37353926)

  • 1. The never-ending battle between lactic acid bacteria and their phages.
    Philippe C; Cornuault JK; de Melo AG; Morin-Pelchat R; Jolicoeur AP; Moineau S
    FEMS Microbiol Rev; 2023 Jul; 47(4):. PubMed ID: 37353926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of phages and bacteria: the co-evolutionary arms race.
    Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y
    Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defense and anti-defense mechanisms of bacteria and bacteriophages.
    Wang X; Leptihn S
    J Zhejiang Univ Sci B; 2024 Feb; 25(3):181-196. PubMed ID: 38453634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Arsenal of Antiviral Defenses. Part II.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.
    Lopatina A; Tal N; Sorek R
    Annu Rev Virol; 2020 Sep; 7(1):371-384. PubMed ID: 32559405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Arsenal of Antiviral Defenses - Part I.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
    Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
    Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Ph)ighting Phages: How Bacteria Resist Their Parasites.
    Rostøl JT; Marraffini L
    Cell Host Microbe; 2019 Feb; 25(2):184-194. PubMed ID: 30763533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveil the Secret of the Bacteria and Phage Arms Race.
    Wang Y; Fan H; Tong Y
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revenge of the phages: defeating bacterial defences.
    Samson JE; Magadán AH; Sabri M; Moineau S
    Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages in the Dairy Industry: A Problem Solved?
    Ortiz Charneco G; de Waal PP; van Rijswijck IMH; van Peij NNME; van Sinderen D; Mahony J
    Annu Rev Food Sci Technol; 2023 Mar; 14():367-385. PubMed ID: 36400015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Engineering of Virulent Lactococcal Phages Using CRISPR-Cas9.
    Lemay ML; Tremblay DM; Moineau S
    ACS Synth Biol; 2017 Jul; 6(7):1351-1358. PubMed ID: 28324650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided discovery of anti-CRISPR and anti-phage defense proteins.
    Duan N; Hand E; Pheko M; Sharma S; Emiola A
    Nat Commun; 2024 Jan; 15(1):649. PubMed ID: 38245560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses.
    Pons BJ; Dimitriu T; Westra ER; van Houte S
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216084120. PubMed ID: 36669116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of Escherichia coli CRISPR-Cas system on lytic bacteriophages with different lifestyles and development strategies.
    Strotskaya A; Savitskaya E; Metlitskaya A; Morozova N; Datsenko KA; Semenova E; Severinov K
    Nucleic Acids Res; 2017 Feb; 45(4):1946-1957. PubMed ID: 28130424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.
    Landsberger M; Gandon S; Meaden S; Rollie C; Chevallereau A; Chabas H; Buckling A; Westra ER; van Houte S
    Cell; 2018 Aug; 174(4):908-916.e12. PubMed ID: 30033365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.